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We report a promising finding that oxidative modification of proteins by free radicals could be monitored by the formation of oxidized hlstidine 
that is detectable by reverse-phase HPLC with electrochemical detection (HPLC-ECD). When the N-protected histidine derivative (N-benzoyl- 
histidine) was exposed to a free radical-generating system (copper/ascorbate), a number of products were detected by HPLC-ECD and the main 
product among them was found to be identical to N-benzoyl-2-oxo-histidine. The acid hydrolysis of N-benzoyl-2-oxo-histidine provided a single 
product (2-oxo-histidine) that was detected sensitively by HPLC-ECD. Thus 2-oxo-histidine was indeed generated as the main product in the 
oxidatively modified proteins by free radicals. Taken together, 2-oxo-histidine may be a useful biological marker for assessing protein modifications 
under oxidative stress. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
A number of systems that generate oxygen free radi- 
cals catalyze the oxidative modification of proteins [l- 
31. Protein oxidation by free radicals contributes to the 
pool of damaged proteins, which increases in size during 
aging and in various pathological states [4]. It has been 
established that oxidative modification of proteins in- 
volves the conversion of amino acids to their oxidized 
forms [2]. Histidine, in general, is one of the amino acids 
most vulnerable to metal-catalyzed free radical reac- 
tions. The conversion of histidine to asparagine has 
been established [2]; however, asparagine may not be an 
appropriate marker for monitoring oxidatively modi- 
fied proteins because it is detected as aspartate in the 
amino acid analysis following acid hydrolysis of oxi- 
dized proteins. These situations prompted us to search 
for a novel biological marker to monitor oxidized his- 
tidine in proteins. 
In this communication, we report a promising proce- 
dure to monitor the oxidized histidine using HPLC with 
electrochemical detection (HPLC-ECD) that permitted 
the detection of the oxidized product with the highest 
specificity. 
*Corresponding author. Fax: (81) (52) 782 9162. 
Abbreviations: HPLC-ECD, high performance liquid chromatogra- 
phy with electrochemical detection. 
2.1. Materials 
N-a-Benzoyl-L-histidine and bovine serum albumin were obtained 
from Sigma. L-Ascorbate, trifluoroacetic acid, and tetrafluorobutyric 
acid were obtained from Wako Pure Chemical Industries Ltd. All 
other reagents were of the highest grade commercially available. 
2.2. Preparation of authentic N-benzoyl-2-oxo-histidine 
The reaction mixture (300 ml) containing 50 mM N-benzoylhistid- 
ine, 50 mM ascorbate, and 0.5 mM C&O, in 50 mM sodium phos- 
phate buffer (pH 7.2) was incubated at room temperature. Oxygen gas 
was bubbled into the mixture for 48 h. Isolation of N-benzoyl-2-oxo- 
histidine was performed with reverse-phase HPLC on a Lop ODS-5 
column (2 x 25 cm). The reaction mixture was concentrated and ap- 
plied to the column equilibrated in a solution of 25% methanol in 0.1% 
trifluoroacetic acid. Products were eluted at a flow rate of 6 ml/min. 
the elution being monitored by absorbance at 230 nm. The main 
product was isolated (yield, 35.7 mg) and its chemical structure was 
characterized by fast atom-bombardment mass spectrometry and ‘H- 
and “C nuclear magnetic resonance spectrometry [5.6]. 
2.3. Preparation of authentic 2-oxo-histidine 
Purified N-benzoyl-2-oxo-histidine was hydrolyzed with 6 N HCI 
in vacua at 105°C for 24 h. The hydrolysate was concentrated and 
dissolved with 50 mM sodium phosphate buffer (pH 7.2). The product 
was purified with reverse-phase HPLC on a TSK-GEL ODS-80TM 
column (0.46 x 25 cm) (TOSOH). The sample was applied to a column 
equilibrated in a solution of 5% methanol in 0.1% heptatmorobutyric 
acid and eluted at a flow rate of 0.8 ml/min, the elution being moni- 
tored by absorbance at 210 nm. HPLC analysis of the hydrolyzed 
sample revealed the formation of a single product and its chemical 
structure was characterized by fast atom-bombardment mass spec- 
trometry and ‘H- and “C nuclear magnetic resonance spectrometry 
[71. 
2.4. Oxidation of N-benzoylhistidine by copperlascorbate 
N-Benzoylhistidine (1 mM) was incubated with 50 PM CuSO, and 
5 mM ascorbate in 1 ml of 50 mM sodium phosphate buffer (pH 7.2) 
at 37°C. An aliquot of the reaction mixture was taken and analyzed 
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by HPLC. The column (TSK-GEL ODS-IOTM) was equilibrated and 
the products were eluted with 20% methanol in 50 mM NaCl solution 
containing 0.1% trifluoroacetic acid at a flow rate of 0.8 ml/min. The 
elution was monitored at 0.85 V of applied oxidation potential on the 
electrochemical detector. 
2.5. Detection of 2-oxo-hrstidine in bovine serum albumin treated with 
copperlascorbate 
Bovine serum albumin (1 mg/ml) in 50 mM sodium phosphate 
buffer (pH 7.2) was treated with 50 PM CuSO, and 5 mM ascorbate 
at 37°C. The reactions were stopped by the addition of 0.1 mM 
EDTA. The reaction mixtures were then treated with 10% trichlo- 
roacetic acid. After centrifugation at 10,000 x g for 3 min, the proteins 
were hydrolyzed with 6 N HCl for 24 h at 105°C. The hydrolysates 
were concentrated and dissolved with 50 mM sodium phosphate 
buffer (pH 7.2). 
The amount of 2-oxo-histidine present in the hydrolysates of the 
protem samples was measured by HPLC-ECD. The column (TSK- 
GEL ODS-IOTM) was equilibrated and the products were eluted with 
50 mM NaCl solution containing 0.1% heptafluorobutyric acid at a 
flow rate of 0.5 ml/min. 2-Oxo-histidine was detected at 0.85 V of 
applied oxidation potential on the electrochemical detector. 
2.6. Amino acid composition 
The amino acid analysis was performed with a JEOL JLC-300 
amino acid analyzer equipped with a JEOL LC30-DK20 data analyz- 
ing system. 
3. RESULTS AND DISCUSSION 
As a preliminary experiment, the histidine derivative 
(N-benzoyl-histidine) oxidatively modified by a free 
radical-generating system (copper/ascorbate) was ana- 
lyzed by HPLC-ECD in order to determine whether or 
not any oxidized products could be detected electro- 
chemically. As shown in Fig. lA, a number of products 
were found to have significantly electrochemical activ- 
ity. Although most of the products have not been iden- 
tified chemically, the main product eluted at 18.2 min 
on the HPLC chromatogram was found to be identical 
to N-benzoyl-2-oxo-histidine that had been discovered 
previously amongst he oxidation products of the histid- 
ine derivative and the histidine-containing peptides ex- 
posed to the copper/ascorbate-free radical-generating 
system [5-71. The fact [7] that the 2-oxo-histidyl moiety 
is resistant o the acid hydrolysis conditions of proteins 
led to the assumption that 2-oxo-histidine, if it is gener- 
ated in proteins, can be monitored by HPLC-ECD. In 
fact, the acid-hydrolysis of N-benzoyl-2-oxo-histidine 
generated a single product (Fig. 1B) that was identical 
to 2-oxo-histidine, and the electrochemical response of 
the hydrolyzed samples increased in a concentration- 
dependent manner for N-benzoyl-2-oxo-histidine (data 
not shown). 
We then attempted to quantify the 2-oxo-histidine 
generated in proteins that had been treated with metal- 
catalyzed free radical-generating systems. As shown in 
Fig. 2, the reaction of copper/ascorbate toward bovine 
serum albumin was selective for histidine residues. We 
found that, concurrent with the loss of histidine, ap- 
proximately 25% of histidine residues was converted to 
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Fig. 1. Detection of Iv’-benzoyl-2-oxo-histidine (A) and its hydrolyzed 
product 2-oxo-histidine (B) by HPLC-ECD. (A) N-benzoylhistidine 
(1 mM) was incubated with 50 ,uM C&O, and 5 mM ascorbate in 1 
ml of 50 mM sodium phosphate buffer (pH 7.2) for 1 h at 37’C. The 
main peak indicated by an arrow at 18.2 min represents N-benzoyl-2- 
oxo-histidine. The starting material (N-benzoylhistidine) was eluted at 
13 min while it did not show ECD response. (B) Authentic N-benzoyl- 
2-oxo-histidine (0.1 mg) was hydrolyzed with 6 N HCl for 24 h at 
105°C. The hydrolysate was concentrated and dissolved with 0.5 ml 
of 50 mM sodium phosphate buffer (pH 7.2). An aliquot (10 ~1) was 
taken and subjected to the HPLC-ECD analysis. The main peak indi- 
cated by arrow at 15.8 min represents 2-oxo-histidine. 
2-oxo-histidine after 30 min of incubation. The yield of 
2-oxo-histidine in this reaction reached a maximum 
(3.78 mol/mol protein) after 1 h of incubation and de- 
creased gradually thereafter, suggesting that 2-oxo-his- 
tidine underwent secondary free radical reactions. 
The 2-oxo-histidine is possibly a ubiquitous oxidized 
material since copper/ascorbate could be replaced by 
Fenton’s reagents (metal/hydrogen peroxide) and 
Udenfriend’s reagents (ironlascorbate) which have been 
implicated as potent free radical-generating systems in 
biological systems [8,9], although the maximum yield of 
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Fig. 2. Loss of histidine and concomitant formation of 2-oxo-histidine 
in bovine serum albumin treated with copperlascorbate. The amount 
of histidine (0) and 2-oxo-histidine (0) was quantitated by amino acid 
analysis and HPLC-ECD, respectively. 
2-oxo-histidine in those systems were lower than that in 
copper/ascorbate: the reaction of bovine serum albumin 
with Fenton’s reagents (0.1 mM Cu2’ and 5 mM H202) 
yielded 0.53 mol of 2-oxo-histidine per mol of protein 
after 30 min of incubation, whereas 0.51 mol of 2-0x0- 
histidine per mol of protein was formed when the pro- 
tein was incubated with Udenfriend’s reagents (0.1 mM 
Fe” and 5 mM ascorbate) for 1 h. Furthermore, 2-0x0- 
histidine has so far been detected in a number of pro- 
teins exposed to oxidative stress in vitro: for example, 
metal-catalyzed oxidative modification of low-density 
lipoprotein (LDL) resulted in the generation of 2-0x0- 
histidine (0.30 nmol/mg LDL) when LDL was incu- 
bated with 10 PM Cu2+ for 24 h, suggesting relevance 
to atherosclerosis. 
Taken together, we have developed a useful probe 
(Zoxo-histidine) that might be applicable to monitoring 
oxidized proteins generated during oxidative stress. 
Several ines of evidence indicate that protein oxidation 
by free radicals and the following accumulation of oxi- 
datively modified proteins, possibly an early indication 
of oxygen radical-mediated tissue damage, have been 
implicated in cells during aging, oxidative stress, and in 
various pathological states, including premature dis- 
eases, muscular dystrophy, rheumatoid arthritis, and 
atherosclerosis. In this regard the procedure using 
HPLC-ECD is crucial since ECD in combination with 
HPLC can raise the specificity in detecting the oxidized 
product. This HPLC-ECD technique has been com- 
monly applied to monitoring Soxo-deoxyguanosine, 
which is an important biological marker for oxidatively 
damaged DNA under oxidative stress [lO-141. It is of 
interest o note that S-oxo-deoxyguanosine has a similar 
2-oxo-imidazole moiety in its molecule (Fig. 3). 
In conclusion, it is not unlikely that, during aging and 
OH 
Fig. 3. Chemical structure of I-oxodeoxyguanosine (A) and 2-0x0- 
histidine (B). 
oxidative stress, the formation of 2-oxo-histidine may 
be involved in the accumulation of modified proteins in 
mammalian cells. However, an assessment of the true 
physiological significance of the conversion of histidine 
to 2-oxo-histidine awaits extension of the study to mam- 
malian sources known to accumulate modified forms of 
proteins during aging and in various pathophysiological 
states. 
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